Hawaii · 2025 Regular Session · Resolution
SR 4: REQUESTING THE AUDITOR TO ASSESS BOTH THE SOCIAL AND FINANCIAL EFFECTS OF PROPOSED MANDATED HEALTH INSURANCE COVERAGE FOR A PERCENTAGE OF THE COSTS OF INTRAVENOUS KETAMINE THERAPY TO TREAT DEPRESSION.
In committee Official data
- Introduced
- In committee
- Passed one chamber
- Passed both chambers
- Enacted
Last official action: ·Record last updated:
Plain-language summary
SR 4 is a resolution introduced in the Hawaii Senate on January 30, 2025. According to its official title, it concerns: REQUESTING THE AUDITOR TO ASSESS BOTH THE SOCIAL AND FINANCIAL EFFECTS OF PROPOSED MANDATED HEALTH INSURANCE COVERAGE FOR A PERCENTAGE OF THE COSTS OF INTRAVENOUS KETAMINE THERAPY TO TREAT DEPRESSION. Primary sponsor: Kurt Fevella (Republican). Most recent recorded action (March 24, 2025): The committee on HHS deferred the measure.
Generated automatically from the official title, sponsor list, and status record only. It does not characterize the bill’s purpose or effects. How summaries are written
Sponsors
Sponsors by party (alphabetical): Republican 1
| Name | Role | Party | Chamber | District |
|---|---|---|---|---|
| Kurt Fevella | Primary sponsor | Republican | Senate | 20 |
“Support” is shown only as formal sponsorship recorded by the legislature. Roll-call votes are available on the official bill page.
Recent official actions
- The committee on HHS deferred the measure.
- The committee(s) on HHS has scheduled a public hearing on 03-24-25 1:05PM; Conference Room 225 & Videoconference.
- Referred to HHS, WAM.
- Offered.